MedPath

Inbios International Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:0
Completed:7

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use

Completed
Conditions
COVID-19
Influenza A
Influenza B
First Posted Date
2024-12-16
Last Posted Date
2025-05-22
Lead Sponsor
InBios International, Inc.
Target Recruit Count
899
Registration Number
NCT06734741
Locations
🇺🇸

Cahaba Research, Birmingham, Alabama, United States

🇺🇸

Medicus Health Research Group Inc, Miami, Florida, United States

🇺🇸

ASR, LLC, Boise, Idaho, United States

and more 7 locations

Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)

Completed
Conditions
Anthrax
First Posted Date
2020-03-25
Last Posted Date
2021-02-10
Lead Sponsor
InBios International, Inc.
Target Recruit Count
450
Registration Number
NCT04320485
Locations
🇺🇸

Fiel Family and Sports Medicine/CCT Research, Tempe, Arizona, United States

🇺🇸

Hometown Urgent Care and Research, Dayton, Ohio, United States

Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA

Completed
Conditions
Zika Virus Infection
First Posted Date
2018-12-17
Last Posted Date
2018-12-17
Lead Sponsor
InBios International, Inc.
Target Recruit Count
600
Registration Number
NCT03776903
Locations
🇺🇸

InBios International, Seattle, Washington, United States

Specificity Study of Diagnostic for Chagas Disease

Completed
Conditions
Infectious Diseases
First Posted Date
2015-09-09
Last Posted Date
2017-08-18
Lead Sponsor
InBios International, Inc.
Target Recruit Count
200
Registration Number
NCT02544139
Locations
🇺🇸

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States

Sensitivity Study of Diagnostic for Detection of Chagas Infection

Completed
Conditions
Infectious Diseases
First Posted Date
2014-05-09
Last Posted Date
2015-12-08
Lead Sponsor
InBios International, Inc.
Target Recruit Count
1601
Registration Number
NCT02134548
Locations
🇧🇴

Universidad Catolica Boliviana San Pablo, Unidad Academica Santa Cruz, (Cei), Santa Cruz, Bolivia

🇨🇱

Laboratorio SANALAB, Santiago, Chile

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.